Next Financial Group’s Albany Molecular Research Inc AMRI Stock Holding History

Next Financial Group’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$2K	–	2039
2017 Q2	$2K	Hold	100	–	–	﹤0.01%	1792
2017 Q1	$2K	Sell	100 -300	-75%	-$4.91K	﹤0.01%	1761
2016 Q4	$8K	Hold	400	–	–	﹤0.01%	1785
2016 Q3	$7K	Buy	400 +300	+300%	+$4.44K	﹤0.01%	1834
2016 Q2	$1K	Hold	100	–	–	﹤0.01%	1714
2016 Q1	$1K	Hold	100	–	–	﹤0.01%	1695
2015 Q4	$1K	Hold	100	–	–	﹤0.01%	1742
2015 Q3	$1K	Hold	100	–	–	﹤0.01%	1783
2015 Q2	$2K	Hold	100	–	–	﹤0.01%	1722
2015 Q1	$1K	Hold	100	–	–	﹤0.01%	1820
2014 Q4	$2K	Sell	100 -150	-60%	-$2.75K	﹤0.01%	1767
2014 Q3	$6K	Hold	250	–	–	﹤0.01%	2013
2014 Q2	$5K	Buy	+250	New	+$4.23K	﹤0.01%	949

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Next Financial Group's AMRI Position: Q3 2017 in Review

Next Financial Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 100 shares — an estimated $2K sold.

Next Financial Group first reported a position in AMRI in Q2 2014 and held it in 13 quarters. The position peaked at $8K in Q4 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Next Financial Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Next Financial Group sold 100 Albany Molecular Research Inc shares in Q3 2017, an estimated $2K.
Next Financial Group first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 13 quarters.
Next Financial Group's Albany Molecular Research Inc position peaked at $8K in Q4 2016.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Next Financial Group's 13F filing for Q3 2017, filed 8 Nov 2017.